DCGI rejects Serum Institute TB vaccine marketing rights
India's drug regulator DCGI denies marketing authorization to Serum Institute's tuberculosis vaccine despite ICMR study backing. Learn how this decision impacts TB eradication efforts.
Category : Search result: DCGI
India's Medical Device Self-Certification Revolution Begins
India's Health Ministry introduces landmark self-certification for low-risk medical devices, replacing complex licensing. This major reform aims to boost domestic manufacturing, reduce import dependency, and accelerate market access for MedTech innovators
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Page 1 of 1